Robert O Young* and Caroline Mansfield

Department of Research, Innerlight Biological Research and Education Foundation, USA

*Corresponding Author: Robert O Young, Department of Research, Innerlight Biological Research and Education Foundation, USA.

Received: October 27, 2025; Published: December 04, 2025

Abstract

Clinoptilolite zeolite has been widely used in environmental remediation and animal feed supplementation, thanks to its unique crystalline structure and ion-exchange properties that enable it to bind and eliminate toxins effectively [1]. In the last 25 years, its application has expanded to include human uses as a detoxifying agent [2].

The nano-, pico-sized colloidal [3] formulation known as MasterPeace^® Zeolite Z^®, developed by Human Consciousness Support™ Company, is a patent-pending combination of micrometre, nanometre, and picometer sized clinoptilolite zeolite with a structured isotonic sea mineral solution [4]. This solution — currently formulated with inland sea minerals and referred to as SOLergy^® — was investigated [5] for its efficacy in reducing aluminium levels in human body fluids and cells. For the purposes of this paper, all references to the intervention product MasterPeace^® Zeolite Z^® are made using the name Zeolite Z^®, which remains unchanged. However, it should be noted that the 35- and 90-day test results reported here are from an earlier pilot study in which the same formulation (Zeolite Z^®) incorporated marine sea plasma rather than the now-used inland sea minerals (SOLergy^®). Baseline results were derived from a subsequent study prior to the introduction of the upgraded SOLergy^® formula, allowing for a consolidated comparison across the two studies.

This analysis integrates data from two related studies. In the larger 24-participant study, baseline aluminium levels were recorded via iEC testing prior to the closure of the testing laboratory in 2024, which prevented follow-up sampling at the 35- and 90-day marks.

However, a previous pilot study using the same product included 35-day and 90-day results for aluminium [6], although aluminium was not among the original baseline markers. In that pilot, aluminium was added as an additional marker at day 35 alongside existing compounds such as heavy metals [7], forever chemicals [8], microplastics [9], micro and nano graphene and glyphosate [10,37,38] and other toxic compounds from the body fluids and cells and then tested again at day 90.

By combining the average baseline results of aluminium from the 24-person study with the 35- and 90-day aluminium levels from the pilot, a clear trend emerges showing a progressive reduction in aluminium over time. These findings are consistent with previously observed detoxification patterns for other toxic compounds and demonstrate that Zeolite Z^® is effective in mobilising and reducing aluminium levels in the human system over a 90-day period. The objective was to determine the safety and efficiency of Zeolite Z^® in detoxification of aluminium.

The study utilised an Intracellular Electrical Capacity (iEC) test to assess blood samples, with baseline measurements taken prior to the beginning of the protocol and follow-up testing conducted at 35 days and 90 days. The test subjects took the Zeolite Z^® natural product daily at a specified dosage of 5 drops sublingually, twice a day. The iEC test [12,17,19] focused on detecting aluminium and other highly toxic substances suspected to be present in the body but not previously measured. This study objective was to determine baseline aluminium levels and assess the effectiveness of Zeolite Z^® in chelating and facilitating the removal of aluminium and related toxic compounds from the system. Evidence from prior human trials has already shown that surface-enhanced clinoptilolite can increase the urinary excretion of toxic metals without disturbing essential mineral balance, supporting its role as a safe in-vivo chelating agent [13]. The sea minerals in Zeolite Z^® are known for their detoxification and remineralisation properties [1], enhancing the product’s overall effectiveness. This ingredient also supports the removal of toxins while replenishing essential minerals in the body [4]. The study aimed to test the combined effects of both nanometre and picometer sized clinoptilolite zeolite and sea minerals in promoting overall detoxification and health. The findings from these tests provide insights into the comprehensive detoxification capabilities of Zeolite Z^®, measuring its impact on reducing aluminium and the toxic burden from extracellular and intracellular fluids [13,16].

 Keywords: Aluminium; Colloid; Clinoptilolite; MasterPeace; iEC Testing; Extracellular; Intracellular; pH; Oxidative; Redox; Reduction; Chelation; Nanometre; Picometer

References

1. Mastinu A., et al. “Zeolite clinoptilolite: therapeutic virtues of an ancient mineral”. Molecules8 (2019): 1517.
2. Kraljević Pavelić S., et al. “Critical review on zeolite clinoptilolite safety and medical applications in vivo”. Frontiers in Pharmacology 9 (2018): 1350.
3. Young RO. “Colloids and colloidal systems in human health and nutrition”. International Journal of Alternative and Complementary Medicine 6 (2016): 95.
4. Lee BH., et al. “Natural sea salt consumption confers protection against hypertension and kidney damage in Dahl salt-sensitive rats”. Food and Nutrition Research1 (2018): 1264713.
5. “Human Consciousness Support”.
6. Young RO. “MasterPeace Zeolite Z pilot study found to be safe and effective in removing nano and micro toxic forever chemicals, heavy metals, microplastics and graphene and aluminium found in the human body cells and fluids”. Acta Scientific Medical Sciences9 (2024): 111-117.
7. Velarde L., et al. “Adsorption of heavy metals on natural zeolites: a review”. Chemosphere 328 (2023): 138508.
8. Hedayati MS., et al. “Removal of perfluoroalkyl acids from aqueous media by surfactant-modified clinoptilolites”. Environmental Science and Pollution Research 31 (2024): 16915- 27.
9. Munir N., et al. “The potential of zeolite nanocomposites in removing microplastics, ammonia, and trace metals from wastewater and their role in phytoremediation”. Environmental Science and Pollution Research 31 (2024): 1695-1718.
10. Young RO. “Oxygenated zeolite (clinoptilolite) efficiently removes aluminium & graphene oxide”.
11. Kraljević Pavelić S., et al. “Novel oxygenated clinoptilolite material efficiently removes aluminium from aluminium chloride- intoxicated rats in vivo”. Microporous and Mesoporous Material 249 (2017): 146-156.
12. IGL-Labor GmbH. “Intracellular Electrical Capacity (iEC) test laboratory reports (unpublished data)”. Germany (2024).
13. Flowers J., et al. “Clinical evidence supporting the use of an activated clinoptilolite suspension as an agent to increase urinary excretion of toxic heavy metals”. Nutritional Diet 1 (2009): 11-18.
14. Pavelić K., et al. “Zeolites in medicine: current achievements and research of zeolites in medicine”. New York (NY Nova Science Publishers) (2019).
15. Pavelić K and Hadžija M. “Medical application of zeolites”. In: Auerbach S, Carrado K, Dutta P, editors. Handbook of Zeolite Sciences and Technology. New York (NY Marcel Dekker) (2003): 1143-1174.
16. Kawahara M and Kato-Negishi M. “Link between aluminium and the pathogenesis of Alzheimer’s disease: the integration of the aluminium and amyloid cascade hypotheses”. International Journal of Alzheimer's Disease 2011 (2011): 276393.
17. Exley C. “Human exposure to aluminium”. Environmental Science: Processes & Impacts10 (2013): 1807-1816.
18. Ford LC., et al. “Hazard and risk characterization and grouping of 56 structurally diverse PFAS using a targeted battery of broad coverage assays in six human cell types”. Toxicology 503 (2024): 153763.
19. Krewski D., et al. “Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide”. Journal of Toxicology and Environmental Health, Part BS1 (2007): 1-269.
20. Exley C. “Aluminium and iron, but neither copper nor zinc, influence the refractive index of transferrin”. Journal of Inorganic Biochemistry11 (2004): 1814-1817.
21. Nehru B and Anand P. “Oxidative damage following chronic aluminium exposure in rat brain and liver”. Indian Journal of Biochemistry and Biophysics5 (2005): 299-302.
22. Seabra AB., et al. “Nanotoxicity of graphene and graphene oxide”. Chemical Research in Toxicology2 (2014): 159-68.
23. Herrala M., et al. “Micro-sized polyethylene particles affect cell viability and oxidative stress responses in human colorectal adenocarcinoma Caco-2 and HT-29 cells”. Science of the Total Environment 856 (2023): 161512.
24. Calhoun A. “Multilayer flexible packaging”. In: Multilayer Flexible Packaging. Elsevier (2010).
25. Zahm S., et al. “Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid”. Lancet Oncology1 (2024): 16-17.
26. Centres for Disease Control and Prevention. “Per- and polyfluorinated substances (PFAS National Biomonitoring Program factsheet”. (2025).
27. Institute for Occupational Safety and Health (IFA). “GESTIS substance database: Perfluorooctanoic acid (PFOA)”. (2025).
28. Prevedouros K., et al. “Sources, fate and transport of perfluorocarboxylates”. Environmental Science & Technology1 (2006): 32-44.
29. Gad SC. In: Wexler P, editor. Encyclopedia of Toxicology. 3^rd Elsevier (2014).
30. Baer KN and Marcel BJ. In: Wexler P, editor. Encyclopedia of Toxicology. 3^rd Elsevier (2014).
31. Das S and Patra CR. In: Handbook of Greener Synthesis of Nanomaterials and Compounds. Elsevier (2021).
32. Shaw I. In: Pesticide Chemistry and Bioscience (1999).
33. Gad SC. In: Wexler P, editor. Encyclopedia of Toxicology. 3^rd Elsevier (2014).
34. D’Haese PC., et al. “Aluminium and bone — studies in patients and experimental animals”. Kidney International 39 (1991): S84-S91.
35. Young RO. “Scanning and transmission electron microscopy reveals graphene oxide in CoV-19 Vaccines”. Acta Scientific Medical Sciences 6 (2022): 98-111.
36. Hwa Yun B., et al. “DNA adducts: formation, biological effects, and new biospecimens for mass spectrometric measurements in humans”. Mass Spectrometry Reviews1-2 (2020): 55-82.
37. Mills PJ., et al. “Excretion of the herbicide glyphosate in older adults between 1993 and 2016”. JAMA16 (2017): 1610-1611.
38. Mesnage R., et al. “Ethoxylated adjuvants of glyphosate-based herbicides are active principles of human cell toxicity”. Toxicology2-3 (2013): 122-128.

Citation

Citation: Robert O Young and Caroline Mansfield. “MasterPeace® Zeolite Z® Study Found to be Safe and Effective in Removing Aluminium, a Toxic Metal in the Human Body Fluids and Cells”.Acta Scientific Medical Sciences 10.1 (2026): 03-11.

Copyright

Copyright: © 2026 Robert O Young and Caroline Mansfield. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.